Sudarshan Pharma Industries Limited IPO (Sudarshan Pharma IPO)

Sudarshan Pharma Industries Limited IPO
Upcoming Sudarshan Pharma IPO | New Sudarshan Pharma IPO

Sudarshan Pharma Industries is engaged in Contract Manufacturing, outsource & Supply of Generic Pharma formulation and medicines to healthcare institution, Government, NGO and Hospitals.

Sudarshan Pharma is also does outsourcing their manufacturing facility, deal in Import and Exports, indenting and Supply in Specialty chemicals, API & its intermediate.

Sudarshan Pharma has developed expertise in innovation in specialty chemical, bulk drugs, API and pharmaceutical formulation to provide the products having wide application in pharma, paint, food and adhesive industry.

Sudarshan Pharma has launched wide products range in pharma formulation such as Jivan Kit, Setdown, Pulmo relief, Fix Pollen, Flupimac and many more as well as have established goodwill for quality products and have regular clients for the same.

The Company has a Contract Manufacturing Agreement with four pharmaceutical companies and has also joined hands with regular suppliers having FDA and WHO approved plant to supply pharma formulation and more than 100 generic pharma products. These units manufacture tablets, capsules, dry powder, dry injections powder, liquids, Injections & dry injections for company’s own brands.

Company’s top clients include Cipla, Larsen & Toubro (Aeronautical division), Berger, Gujarat Insecticides, Huntsman, Navin Flourine Industries, Insecticides India Ltd, Isia (Asia) Agrochemicals Pvt Ltd, SRF Ltd, Clean Science and Technology Pvt Ltd, Songwon Speciality Chemicals-India Pvt. Ltd to name a few.

Sudarshan Pharma has exported to countries like Uzbekistan, Bangladesh, Taiwan, Sultanate of Oman, (Muscat) Dubai, (UAE) & UK. Further, the company has a product pipeline ready for exports in countries like South East Asia, Middle East & North Africa.

Sudarshan Pharma IPO

Sudarshan Pharma IPO – Details

IPO Opening Date09 March 2023
IPO Closing Date14 March 2023
Issue TypeBook Built Issue IPO
Issue Size68,62,400 Shares Worth ₹50.10 Crore
Fresh Issue: 68,62,400 Shares Worth ₹50.10 Crore
Face Value₹10 per equity share
IPO Price₹71-₹73
Market Lot1600 Shares
Min Order11600 Shares (1 Lot)
Listing AtBSE SME
RegisterKFin Technologies Private Limited
QIB Shares Offered50%
Retail Shares Offered35%
NII (HNI) Shares Offered15%

Sudarshan Pharma IPO – Date Schedule

IPO Open Date09 March 2023
IPO Close Date14 March 2023
Basis of Allotment17 March 2023
Initiation of Refunds20 March 2023
Credit of Shares to Demat Account21 March 2023
IPO Listing Date22 March 2023

Sudarshan Pharma IPO – Lots Size & Price

ApplicationLotsSharesAmount ( Cut-Off)
Minimum116001,16,800
Maximum116001,16,800

Competitive Strengths

  • Venturing into API manufacturing.
  • Focus on increasing the global sales.
  • Increasing Operational efficiency.
  • Broaden and Deepen Presence in the existing product portfolio.
  • Increase by targeting unexplored markets.
  • Expand the scope by adding more products.

Company Promoters

  • Mr. Hemal Vasantrai Mehta
  • Mr. Sachin Vasantrai Mehta

Object Of The Issue

  • Working Capital Requirements.
  • General Corporate Expenses.
Sudarshan Pharma IPO
Issue Object

Company Financial

ParticularsTotal RevenueTotal ExpenseProfit After Tax
31 March 2020148.00146.281.27
31 March 2021193.72190.152.67
31 March 2022357.55350.365.30
30 September 2022195.89191.083.60
Amount in ₹ Crore

Sudarshan Pharma IPO Promoter Holding

Pre Issue Share Holding80.28%
Post Issue Share Holding

Sudarshan Pharma IPO Prospectus

Company Contact Information

Sudarshan Pharma Industries Limited

301,3rd Floor, Aura Biplex, Above Kalyan
Jewellers S. V. Road, Borivali (West)
Mumbai City Maharashtra 400092 India.

Phone: 022- 42221111
Email: compliance@sudarshanpharma.com
Websitewww.sudarshanpharma.com

Sudarshan Pharma IPO Registrar

KFin Technologies Private Limited

Phone: +91 40 6716 2222
Email: einward.ris@kfintech.com
Websitewww.kfintech.com

Sudarshan Pharma IPO Lead Manager(s)

1. Gretex Corporate Services Limited

Sudarshan Pharma IPO FAQs

Sudarshan Pharma IPO FAQs
What is Sudarshan Pharma IPO?

Sudarshan Pharma IPO is a SME IPO. The issue is priced at ₹71-₹73 per equity share. The IPO is to be listed on BSE SME.
When Sudarshan Pharma IPO will open?

The IPO is to open on  09 March 2023 for NII and Retail Investors.
What is Sudarshan Pharma IPO Investors Portion?

The investors portion for QIB- 50%, NII-15%, and Retail-35%.
How to Sudarshan Pharma IPO?

You can apply Sudarshan Pharma IPO via ASBA online via your bank account. You can also apply for ASBA online via UPI through your stock brokers. You can also apply via your stock brokers by filling up the offline form.
How to Apply the Sudarshan Pharma IPO through 5 Paisa?

Log in to 5 Paisa Application with your credentials. Select the IPO. You will see the IPO Name “Sudarshan Pharma”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with 5 Paisa.
How to Apply the Sudarshan Pharma IPO through Edelweiss?

Log in to Angle One Application with your credentials. Select the IPO. You will see the IPO Name “Sudarshan Pharma”. Click on Bid Button. Confirm your Application. Now go to your UPI App on Net Banking or BHIM App to Approve the mandate. Open Demat Account with Edelweiss.
What is Sudarshan Pharma IPO Size?

Sudarshan Pharma IPO size is ₹[] crores.
What is Sudarshan Pharma IPO Price Band?

Sudarshan Pharma IPO Price Band is ₹71-₹73.
What is Sudarshan Pharma IPO Minimum and Maximum Lot Size?

The minimum bid is 1600 Shares with ₹1,16,800 amount while the maximum bid is 1600 shares with  ₹1,16,800.
What is the Sudarshan Pharma IPO Allotment Date?

Sudarshan Pharma IPO allotment date is  17 March 2023.
What is the Sudarshan Pharma IPO Listing Date?

Sudarshan Pharma IPO listing date is 22 March 2023. The IPO is to list on BSE SME.
Share Market IPO App
Previous articleGlobal Surfaces Limited IPO (Global Surfaces IPO)
Next articleProspect Commodities Limited IPO (Prospect Commodities IPO)